13F reference period
Q2 2026
Security Snapshot
Oaktree Acquisition Corp. III Life Sciences - Class A ordinary shares, par value $0.0001 per share (OACCW) Institutional Ownership
CUSIP: G6717R112
13F Institutional Holders and Ownership History from Q4 2024 to Q3 2026
Institutions Reporting
29
Shares (Excl. Options)
2.83M
Full value: 2,829,891 · shares · 30 Jun 2026Price
$0.94
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Class A ordinary shares, par value $0.0001 per share
- Symbol
- OACCW on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 2,829,891
- Total 13F value
- $2,651,830
- Portfolio coverage rank
- 0%
- Share change
- +35,334
- Value change
- +$44,294
- Number of holders
- 29
- Shares outstanding
- 19,607,843
- SEC-reported price per share
- $0.95
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- OACCW - Oaktree Acquisition Corp. III Life Sciences - Class A ordinary shares, par value $0.0001 per share is tracked under CUSIP G6717R112.
- 29 institutions reported positions in Q2 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 27 to 29 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$2.07M
Full value: $2,066,215 · USD · 31 Mar 2026.$2.65M
Full value: $2,651,830 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 29 institutions filings for Q2 2026.
Security key
G6717R112
13F reference period
Q2 2026
13F holders
29
13D/G owners
2
CIK / CUSIP context first
Open Q2 2026 holders
OACCW full holder history
Oaktree Acquisition Corp. III Life Sciences SEC filings
Oaktree Acquisition Corp. III Life Sciences company facts
Oaktree Acquisition Corp. III Life Sciences insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP G6717R112:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
OACCW
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| GOLDMAN SACHS GROUP INC | 6.2% | $898,402 | 1,228,500 | THE GOLDMAN SACHS GROUP, INC. | 31 Mar 2026 | |||
| Fort Baker Capital Management LP | 5.1% | $750,000 | 1,000,000 | Fort Baker Capital Management LP | 31 Mar 2026 |
As of 30 Jun 2026,
29
institutional investors reported holding
shares of
Oaktree Acquisition Corp. III Life Sciences - Class A ordinary shares, par value $0.0001 per share (OACCW).
This represents
14%
of the company’s total
outstanding shares.
2.83M
Full value: 2,829,891 · shares · 30 Jun 202619.61M
Full value: 19,607,843 · shares · Stored outstanding share count13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
14%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | 1.7% | 340,000 | 0% | 0% | $323,000 |
| AQR Arbitrage LLC | 1.4% | 282,120 | 0% | 0% | $251,087 |
| TORONTO DOMINION BANK | 0.97% | 189,816 | +9.6% | 0% | $178,617 |
| Walleye Capital LLC | 0.86% | 169,502 | 0% | 0% | $159,569 |
| Decagon Asset Management LLP | 0.83% | 162,702 | 0% | 0.03% | $153,168 |
| BOUSSARD & GAVAUDAN GESTION SAS | 0.77% | 150,000 | 0% | 0.02% | $133,500 |
| JPMORGAN CHASE & CO | 0.74% | 145,000 | 0% | 0% | $129,050 |
| Weiss Asset Management LP | 0.74% | 144,767 | 0% | 0% | $137,529 |
| Linden Advisors LP | 0.61% | 120,000 | 0% | 0% | $126,600 |
| BNP PARIBAS FINANCIAL MARKETS | 0.54% | 105,907 | 0% | 0% | $99,701 |
| MOORE CAPITAL MANAGEMENT, LP | 0.54% | 105,000 | 0% | 0% | $98,847 |
| Shaolin Capital Management LLC | 0.51% | 100,625 | -11% | 0.01% | $94,728 |
| Alberta Investment Management Corp | 0.51% | 100,000 | 0% | 0% | $94,140 |
| LMR Partners LLP | 0.48% | 95,000 | 0% | 0% | $89,433 |
| Periscope Capital Inc. | 0.46% | 90,000 | 0% | 0.01% | $84,726 |
| GRITSTONE ASSET MANAGEMENT LLC | 0.4% | 78,981 | 0% | 0.07% | $74,353 |
| Lineage Point Capital LP | 0.4% | 78,928 | 0.02% | $74,303 | |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 0.31% | 60,000 | 0% | 0% | $56,484 |
| ExodusPoint Capital Management, LP | 0.31% | 60,000 | 0% | 0% | $56,484 |
| WHITEBOX ADVISORS LLC | 0.26% | 50,000 | 0% | 0% | $47,070 |
| Sculptor Capital LP | 0.26% | 50,000 | 0% | 0% | $47,070 |
| DLD Asset Management, LP | 0.23% | 44,519 | 0% | $41,910 | |
| K2 PRINCIPAL FUND, L.P. | 0.21% | 40,369 | +3.4% | 0% | $37,947 |
| Verition Fund Management LLC | 0.12% | 23,790 | -2.3% | 0% | $22,601 |
| Schonfeld Strategic Advisors LLC | 0.08% | 16,500 | -68% | 0% | $15,533 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
8
Headline period
Q2 2026
Rows shown
1-8 of 8
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 0 | $0 | -$74,353 | $0.95 | 0 |
| 2026 Q2 | 2,829,891 | $2,651,830 | +$44,294 | $0.94 | 29 |
| 2026 Q1 | 2,794,557 | $2,066,215 | -$34,998 | $0.75 | 27 |
| 2025 Q4 | 2,851,427 | $2,088,196 | -$35,774 | $0.71 | 30 |
| 2025 Q3 | 2,795,078 | $2,186,394 | +$67,244 | $0.75 | 28 |
| 2025 Q2 | 2,705,418 | $2,337,889 | +$320,116 | $0.88 | 27 |
| 2025 Q1 | 2,338,904 | $1,736,882 | +$874,783 | $0.75 | 23 |
| 2024 Q4 | 1,151,794 | $941,930 | +$711,698 | $0.88 | 12 |